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marginal OPs on XR to that on DTS using a compartmental approach. The
study population was part of a larger study of random volunteers assessing
the diagnostic performance of a novel X-ray device (DTS). All subjects (aged
≥40 years, with or without knee pain or knee OA) had both knees imaged
by DTS, XR and 1.5T MRI. OPs were deﬁned as WORMS grade ≥1 (scale
0-7) on MRI, and on plain PA semiﬂexed knee XR (using Synaﬂexer™ and
DTS as OARSI grade ≥1 (scale 0-3). Knee pain was assessed using WOMAC
score. We calculated the sensitivity and speciﬁcity for DTS and XR for
detection of OPs, using MRI as the reference standard. Logistic regression
was used to assess the association of pain with the presence of OPs in each
compartment. Zero-inﬂated Poisson regression model with random effects
was used to take the effect of clustering into account.
Results: Eighty knees (40 subjects) were imaged. The mean age of subjects
was 57 (SD ±11) years, 30 (75%) were women, 35 (88%) were White and
31 (78%) had a body mass index ≥25 kg/m2. Prevalence of OPs on MRI was
48 in lateral femoral, 39 in medial femoral, 45 in lateral tibial, 39 in medial
tibial compartments. The sensitivity of DTS for OP detection was 0.98, 0.97,
1.00, and 1.00, respectively, and was superior to XR (0.73, 0.79, 0.87, and
0.90) in all compartments. DTS was signiﬁcantly superior to XR in both
femoral (p=0.0005 and 0.029) and lateral tibial compartments (p=0.026).
Differences were not signiﬁcant for speciﬁcity (DTS: 0.97, 0.98, 0.89, and
0.93; XR: 1.00, 1.00, 0.91, and 0.83). For DTS, association between pain and
prevalent OPs was seen in all compartments (Odds ratio (OR)=4.4, 6.4, 4.2,
and 5.7; all p<0.02), but OPs detected by XR appeared to be more strongly
associated with pain in all compartments (OR=5.0, 8.4, 5.9, and 6.3; all
p<0.004).
Table 1. Prevalence of marginal osteophytes detected by XR, DTS and MRI
Modality Compartment Knee
Left Right ALL
N % N % N %
XR Lateral femur 18 45 17 43 35 44
Medial femur 18 45 13 33 41 39
Lateral tibia 23 58 19 48 42 53
Medial tibia 23 58 19 48 42 53
DTS Lateral femur 24 60 24 60 48 60
Medial femur 21 53 18 45 39 49
Lateral tibia 25 63 24 60 49 61
Medial tibia 22 55 20 50 42 53
MRI Lateral femur 24 60 24 60 48 60
Medial femur 21 53 18 45 39 49
Lateral tibia 22 55 23 58 45 56
Medial tibia 21 53 18 45 39 49
Table 2. Diagnostic performance of XR and DTS for detection of marginal osteophytes
Modality Compartment Sensitivity Speciﬁcity Accuracy
(%) (%) (%)
XR Lateral femur 73 100 79
Medial femur 79 100 90
Lateral tibia 87 91 89
Medial tibia 90 83 86
DTS Lateral femur 98* 97 98
Medial femur 97* 98 98
Lateral tibia 100* 89 95
Medial tibia 100 93 96
Table 3. Relationship between marginal osteophytes and pain, tested by logistic regres-
sion analysis
Modality Compartment Odds Ratio p-value
XR Lateral femur 5.0 0.0037
Medial femur 8.4 0.0005
Lateral tibia 5.9 0.0019
Medial tibia 6.3 0.0012
DTS Lateral femur 4.4 0.0095
Medial femur 6.4 0.0011
Lateral tibia 4.2 0.011
Medial tibia 5.7 0.0023
Conclusions: DTS offers higher sensitivity for detection of OPs in both
femoral and lateral tibial compartments. OPs that DTS detects are associ-
ated with pain, but OPs that XR misses may be clinically less important.
Digital tomosynthesis offers superior detection of osteophytes than plain
X-rays, and thus may potentially be used to establish the radiographic
diagnosis of OA in a clinical and research setting.
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EXPERIMENTAL VALIDATION OF 99MTC-NTP 15-5 AS A RADIOTRACER FOR
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Purpose: When considering the pathophysiologic basis of the degenerative
pathologies of cartilage, proteoglycans (PG) appear as one of the primary
targets for both the diagnosis and the therapy. Our lab develops a “cartilage
targeting strategy” for nuclear medicine applications with the 99mTc-NTP
15-5 radiotracer that selectively binds to cartilage PG in vitro and in vivo.
The purpose of this presentation is to report preclinical data in favour
of the clinical transfer of 99mTc-NTP 15-5 as a radiopharmaceutical for
functional imaging of cartilage.
Methods: We have assessed the pertinence of 99mTc-NTP 15-5 radiotracer
for in vivo scintigraphic imaging of cartilage in preclinical animal models:
(i) healthy animals and several animal species, (ii) in meniscectomized
(MNX) animals developing osteoarthritis (OA).
99mTc-NTP 15-5 monitoring of OA was performed at regular intervals over
6 months after unilateral medial meniscectomy. (Sham operated animals
were also monitored in the same conditions). Tracer uptake was quantiﬁed
in vivo using standardized region-of interest-method and expressed as
uptake ratios (i.e. uptake of operated knee/uptake of contralateral knee).
99mTc-NTP 15-5 imaging was compared with bone scintigraphy. Moreover,
99mTc-NTP 15-5 uptake by human articular cartilage specimens was as-
sessed after ex vivo incubation. For these experiments, 6 osteoarthritic
tibial plateaux providing from prosthesis surgery and two femorotibial
joints providing from anatomy laboratory were incubated with 99mTc-NTP
15-5 for 30 min or 2h. SPECT/CT imaging was then performed and tracer
uptake quantiﬁed using based-region-growing SPECT/CT method. Results
were expressed as % incubated dose (ID) and also as cartilage/bone uptake
ratio
Results: In healthy animals and many animal species (i.e. rabbit, guinea
pig, rat, mouse), a high and speciﬁc accumulation of 99mTc-NTP 15-5 was
observed in cartilage (about 5.5±1.7% of Injected Dose/g of tissue at 15
min after iv injection). 99mTc-NTP 15-5 accumulation was demonstrated
by whole knee autoradiography to be restrained to medial and lateral
compartments of the joint, with a very low accumulation within bone and
muscle (<0.1% ID/g).
In MNX animals, 99mTc-NTP 15-5 accumulation in cartilage within the
operated joint was observed to change in the same animals as pathology
progressed. Scintigraphic ratio time course evidenced (1) an initial “in-
creased scintigraphic ratio phase” associated to an hypertrophic response
of cartilage (2) a “decreased scintigraphic ratio phase” correlated with a
decrease in proteoglycan content. No change in bone radiotracer uptake
was observed throughout 6 months.
For experiments with human articular cartilage, analysis of SPECT/CT
fused images evidenced selective and intense uptake of 99mTc-NTP 15-5
within cartilage, and a low accumulation within bone and soft tissues.
Cartilage/ bone uptake ratios were 2.2±0.2. Interestingly, regions of OA
specimens of decreased radiotracer accumulation on SPECT images were
clearly colocalized with areas of cartilage defect, as visualised by CT.
Conclusions: These experimental results provided relevant key data in
favour of the clinical transfer of 99mTc-NTP 15-5, as a radiopharmaceutical
for an early speciﬁc diagnosis and staging of OA in nuclear medicine.
Grants: Fondation pour la recherche Medicale; Regional Innovation Fund
(FRi2)/OSEO.
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Purpose: The spatial distribution of bone marrow lesions (BML) may
provide complimentary data to the existing semi-quantitative analysis and
Poster Presentations / Osteoarthritis and Cartilage 18, Supplement 2 (2010) S45–S256 S193
increase our understanding of their importance in osteoarthritis (OA). This
study compares the distribution of BMLs with the distribution of denuded
bone in a group of OA subjects
Methods: 88 individuals were selected from the OAI progression groups
0.B.1 and 1.B.1. The subjects chosen had K-L scores of 2 or 3; medial
JSN > lateral JSN, medial osteophytes and ≥1° of varus mal-alignment.
OA related bone marrow lesions were deﬁned as poorly delineated region
of hyperintensity located in the subchondral bone, excluding the region
adjacent to ligament attachment sites. TSE and DESS-we images were
manually segmented using EndPoint software (Imorphics, Manchester, UK),
with the segmenter blinded as to time point, but not to subject.
A method for measurement of cartilage thickness was adapted to measure
the amount of BML adjacent to the bone surface. A statistical model of bone
was ﬁtted to each image, generating a set of anatomically corresponded
points on the femur, tibia and patella. The amount of BML adjacent to
each corresponded point is measured by taking a normal from each point
15mm into the bone and recording the number of BML voxels traversed by
the normal. At each point on the surface this provides a measure of BML
‘thickness’ adjacent to that point. Cartilage thickness was calculated in the
same way, using normals projecting out from the bone.
The association of BML and denudation was also measured semi-
quantitatively using visualizations as shown in Figure 2. BMLs were
scored as either overlapping or adjacent to denuded bone, or not.
The distribution of bone marrow lesions in this population shows a clear
pattern (Figure 1). In the femur, BMLs are found predominantly in the
patellofemoral joint both medially and laterally, and in the medial femoro-
tibial joint. They are almost completely absent in the lateral femoro-tibial
joint. In the tibia BMLs are primarily found in the medial tibial compart-
ment. In the patella BMLs are found across the whole joint, with slightly
greater density on the lateral facet.
Figure 1. Distribution of BMLs in population. Figure shows average amount of bone mar-
row lesion across the surface of femur, tibia and patella. Scale is the mean number of BML
voxels within 15 mm of the surface.
Abstract 432 – Figure 2. 6 representative subjects showing BML location and thickness (number of BML voxels adjacent to bone surface) and denuded bone as grey mask on the baseline
image for each subject.
Table 1. Proportion of BMLs by compartment which overlap or are adjacent to areas of
denuded cartilage
All Femur FP Femur FT Tibia Patella
Med Lat Med Lat MT LT MP LP
BMLs which overlap or are
adjacent to denuded bobe 153 25 19 24 4 50 3 6 22
Total number of BML 199 28 27 37 7 53 7 10 30
(%) (77) (89) (70) (65) (57) (94) (43) (60) (73)
In the baseline images 76.9% of all BMLs either overlapped or were adjacent
to denuded bone (Table 1). Figure 2 shows the closeness of this relationship
in 6 individuals whose pattern of denudation and BMLs was quite typical
for this population. BMLs in the femoro-tibial joint and the lateral tibia
overlapped less with denuded but were typically much smaller than those
of the patellofemoral joint and patella. Separately we observed that there
was no obvious correlation with BMLs and change in cartilage thickness
(results not shown); in particular signiﬁcant cartilage change was not seen
in the patellofemoral joint of the femur, or in the patella.
Conclusions: A novel method of measurement and display of BMLs demon-
strates that there is a striking similarity between the spatial distribution of
BMLs and denuded bone in subjects with OA. Application of this method to
compare BML with other outcomes may provide greater understanding of
structural change in this disease
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Purpose: KL is the most widely used radiographic scale to deﬁne HOA, as-
sess HOA severity and follow-up radiographic progression. Though widely
used for case-deﬁnition, its interobserver reliability is usually low in HOA.
Objectives: To study the impact of a new KL Scoring System Aid (KLSSA)
on the reliability of KL scoring.
